This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamauchi, K. Articles by Hoffman, R. M. Search for Related Content PubMed PubMed Citation Articles by Yamauchi, K. Articles by Hoffman, R. M.

Induction of Cancer Metastasis by Cyclophosphamide Pretreatment of Host Mice: An Opposite Effect of Chemotherapy

¹ AntiCancer, Inc.; ² Department of Surgery, University of California, San Diego, California; and ³ Department of Orthopedic Surgery, School of Medicine, Kanazawa University, Ishikawa, Japan

Requests for reprints: Robert M. Hoffman, AntiCancer, Inc., San Diego, CA 92111. Phone: 858-654-2555; Fax: 858-268-4175; E-mail: all{at}anticancer.com.

Although side effects of cancer chemotherapy are well known, "opposite effects" of chemotherapy that enhance the malignancy of the treated cancer are not well understood. In this report, we describe the induction of intravascular proliferation, extravasation, and colony formation by cancer cells, critical steps of metastasis, by pretreatment of host mice with the commonly used chemotherapy drug cyclophosphamide. In contrast, in the unpretreated mice, most cancer cells remained quiescent in vessels without extravasation. HT1080 human fibrosarcoma cells, labeled in the nucleus with green fluorescent protein and red fluorescent protein in the cytoplasm for imaging, were injected into the epigastric cranialis vein of nude mice. Twenty-four hours before cancer cell injection, cyclophosphamide was given i.p. Double-labeled cancer cells were imaged at the cellular level in live mice with the Olympus OV100 Small Animal Imaging System with variable magnification. Cyclophosphamide seems to interfere with a host process that inhibits intravascular proliferation, extravasation, and extravascular colony formation. Cyclophosphamide does not directly affect the cancer cells because cyclophosphamide has been cleared by the time the cancer cells were injected. This report shows an important unexpected "opposite effect" of chemotherapy that enhances critical steps in malignancy rather than inhibiting them, suggesting that certain current approaches to cancer chemotherapy should be modified. [Cancer Res 2008;68(2):516–20]

This article has been cited by other articles:

				Q.-Q. Li, J.-D. Xu, W.-J. Wang, X.-X. Cao, Q. Chen, F. Tang, Z.-Q. Chen, X.-P. Liu, and Z.-D. Xu Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells Clin. Cancer Res., April 15, 2009; 15(8): 2657 - 2665. [Abstract] [Full Text] [PDF]

				K. Jahnke, L. L. Muldoon, C. G. Varallyay, S. J. Lewin, R. D. Brown, D. F. Kraemer, C. Soussain, and E. A. Neuwelt Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma Neuro-oncol, January 1, 2009; 11(5): 503 - 513. [Abstract] [Full Text] [PDF]